Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Holman

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Tissue Antigens|February 1, 1995
Comparison of HLA-DRB1 typing by DNA-RFLP, PCR-SSO and PCR-SSP methods and their application in providing matched unrelated donors for bone marrow transplantationF Jordan, A J McWhinnie, S Turner, et al.
Plos One|January 14, 2020
Fibrin hydrogels are safe, degradable scaffolds for sub-retinal implantationJarel K Gandhi, Fukutaro Mano, Raymond Iezzi, et al.
Clinical and Vaccine Immunology : CVI|July 20, 2007
Complex adenovirus-mediated expression of West Nile virus C, PreM, E, and NS1 proteins induces both humoral and cellular immune responsesJennifer Schepp-Berglind, Min Luo, Danher Wang, et al.
The American Journal of Tropical Medicine and Hygiene|April 12, 2007
Induction of bivalent immune responses by expression of dengue virus type 1 and type 2 antigens from a single complex adenoviral vectorNicholas U Raja, David H Holman, Danher Wang, et al.
Cancer Gene Therapy|March 18, 2006
FasL gene therapy: a new therapeutic modality for head and neck cancerS ElOjeimy, J C McKillop, A M El-Zawahry, et al.
Current Eye Research|November 19, 2019
Diet Mimicking "Fast Food" Causes Structural Changes to the Retina Relevant to Age-Related Macular DegenerationGavin W Roddy, Robert H Rosa, Kimberly B Viker, et al.
FEBS Letters|August 12, 2006
New insights on the use of desipramine as an inhibitor for acid ceramidaseSaeed Elojeimy, David H Holman, Xiang Liu, et al.
Investigative Ophthalmology & Visual Science|May 25, 2017
Stanniocalcin-1 Is an Ocular Hypotensive Agent and a Downstream Effector Molecule That Is Necessary for the Intraocular Pressure-Lowering Effects of LatanoprostGavin W Roddy, Kimberly B Viker, Nelson S Winkler, et al.
Plos One|April 17, 2020
Pharmacological and pharmacokinetic profile of the novel ocular hypotensive prodrug CKLP1 in Dutch-belted pigmented rabbitsUttio Roy Chowdhury, Rachel A Kudgus, Tommy A Rinkoski, et al.
Cancer Chemotherapy and Pharmacology|April 13, 2007
Lysosomotropic acid ceramidase inhibitor induces apoptosis in prostate cancer cellsDavid H Holman, Lorianne S Turner, Ahmed El-Zawahry, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Tissue Antigens|February 1, 1995
Comparison of HLA-DRB1 typing by DNA-RFLP, PCR-SSO and PCR-SSP methods and their application in providing matched unrelated donors for bone marrow transplantationF Jordan, A J McWhinnie, S Turner, et al.
Plos One|January 14, 2020
Fibrin hydrogels are safe, degradable scaffolds for sub-retinal implantationJarel K Gandhi, Fukutaro Mano, Raymond Iezzi, et al.
Clinical and Vaccine Immunology : CVI|July 20, 2007
Complex adenovirus-mediated expression of West Nile virus C, PreM, E, and NS1 proteins induces both humoral and cellular immune responsesJennifer Schepp-Berglind, Min Luo, Danher Wang, et al.
The American Journal of Tropical Medicine and Hygiene|April 12, 2007
Induction of bivalent immune responses by expression of dengue virus type 1 and type 2 antigens from a single complex adenoviral vectorNicholas U Raja, David H Holman, Danher Wang, et al.
Cancer Gene Therapy|March 18, 2006
FasL gene therapy: a new therapeutic modality for head and neck cancerS ElOjeimy, J C McKillop, A M El-Zawahry, et al.
Current Eye Research|November 19, 2019
Diet Mimicking "Fast Food" Causes Structural Changes to the Retina Relevant to Age-Related Macular DegenerationGavin W Roddy, Robert H Rosa, Kimberly B Viker, et al.
FEBS Letters|August 12, 2006
New insights on the use of desipramine as an inhibitor for acid ceramidaseSaeed Elojeimy, David H Holman, Xiang Liu, et al.
Investigative Ophthalmology & Visual Science|May 25, 2017
Stanniocalcin-1 Is an Ocular Hypotensive Agent and a Downstream Effector Molecule That Is Necessary for the Intraocular Pressure-Lowering Effects of LatanoprostGavin W Roddy, Kimberly B Viker, Nelson S Winkler, et al.
Plos One|April 17, 2020
Pharmacological and pharmacokinetic profile of the novel ocular hypotensive prodrug CKLP1 in Dutch-belted pigmented rabbitsUttio Roy Chowdhury, Rachel A Kudgus, Tommy A Rinkoski, et al.
Cancer Chemotherapy and Pharmacology|April 13, 2007
Lysosomotropic acid ceramidase inhibitor induces apoptosis in prostate cancer cellsDavid H Holman, Lorianne S Turner, Ahmed El-Zawahry, et al.
Pageof 7